128 related articles for article (PubMed ID: 7510146)
1. Fc gamma receptor II (CD32) on malignant B cells influences modulation induced by anti-CD19 monoclonal antibody.
Vervoordeldonk SF; Merle PA; van Leeuwen EF; van der Schoot CE; von dem Borne AE; Slaper-Cortenbach IC
Blood; 1994 Mar; 83(6):1632-9. PubMed ID: 7510146
[TBL] [Abstract][Full Text] [Related]
2. Effect of isotype on internalization and cytotoxicity of CD19-ricin A immunotoxins.
van Oosterhout YV; van den Herik-Oudijk IE; Wessels HM; de Witte T; van de Winkel JG; Preijers FW
Cancer Res; 1994 Jul; 54(13):3527-32. PubMed ID: 7516821
[TBL] [Abstract][Full Text] [Related]
3. Response of human platelets to activating monoclonal antibodies: importance of Fc gamma RII (CD32) phenotype and level of expression.
Tomiyama Y; Kunicki TJ; Zipf TF; Ford SB; Aster RH
Blood; 1992 Nov; 80(9):2261-8. PubMed ID: 1421396
[TBL] [Abstract][Full Text] [Related]
4. Preclinical studies with radiolabeled monoclonal antibodies for treatment of patients with B-cell malignancies.
Vervoordeldonk SF; Merle PA; van Leeuwen EF; von dem Borne AE; Slaper-Cortenbach IC
Cancer; 1994 Feb; 73(3 Suppl):1006-11. PubMed ID: 8306242
[TBL] [Abstract][Full Text] [Related]
5. Direct demonstration of binding of aggregated mouse IgG1 to the 40-kDa Fc receptor for IgG (Fc gamma RII) in both high and low responders.
Möst J; Glassl H; Gattringer C; Neumayer HP; Schulz TF; Dierich MP; Huber H
Immunol Lett; 1992 Apr; 32(2):159-65. PubMed ID: 1377171
[TBL] [Abstract][Full Text] [Related]
6. Cross-linking of both types of IgG Fc receptors, Fc gamma RI and Fc gamma RII, enhances intracellular free Ca2+ in the monocytic cell line U937.
van de Winkel JG; Tax WJ; Jacobs CW; Huizinga TW; Willems PH
Scand J Immunol; 1990 Mar; 31(3):315-25. PubMed ID: 2157275
[TBL] [Abstract][Full Text] [Related]
7. My4+/LeuM3- molecule and CD19 antigen are down-modulate by low affinity Fc gamma receptor II (CD32) stimulation on CD56-positive B-lymphoma cells.
Ikemoto T; Nakagawa T; Hatanaka M; Hasegawa M; Kageyama T; Hirano M; Shimizu A
Leuk Lymphoma; 2000 Sep; 39(1-2):157-64. PubMed ID: 10975395
[TBL] [Abstract][Full Text] [Related]
8. A superantigen-antibody fusion protein for T-cell immunotherapy of human B-lineage malignancies.
Gidlöf C; Dohlsten M; Lando P; Kalland T; Sundström C; Tötterman TH
Blood; 1997 Mar; 89(6):2089-97. PubMed ID: 9058731
[TBL] [Abstract][Full Text] [Related]
9. Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6.
Duits AJ; Aarden LA; Ernst LK; Capel PJ; van de Winkel JG
Clin Exp Immunol; 1993 May; 92(2):225-31. PubMed ID: 8485907
[TBL] [Abstract][Full Text] [Related]
10. Activity of two types of Fc receptors, Fc gamma RI and Fc gamma RII, in human monocyte cytotoxicity to sensitized erythrocytes.
van de Winkel JG; Boonen GJ; Janssen PL; Vlug A; Hogg N; Tax WJ
Scand J Immunol; 1989 Jan; 29(1):23-31. PubMed ID: 2522235
[TBL] [Abstract][Full Text] [Related]
11. Antibody-induced modulation and intracellular transport of CD10 and CD19 antigens in human malignant B cells.
Pulczynski S
Leuk Lymphoma; 1994 Oct; 15(3-4):243-52. PubMed ID: 7532507
[TBL] [Abstract][Full Text] [Related]
12. Effective lysis of lymphoma cells with a stabilised bispecific single-chain Fv antibody against CD19 and FcgammaRIII (CD16).
Bruenke J; Barbin K; Kunert S; Lang P; Pfeiffer M; Stieglmaier K; Niethammer D; Stockmeyer B; Peipp M; Repp R; Valerius T; Fey GH
Br J Haematol; 2005 Jul; 130(2):218-28. PubMed ID: 16029450
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Fc gamma receptor mediated T-cell activation by two purified CD3 x CD19 bispecific monoclonal antibodies with hybrid Fc domains.
Haagen IA; Geerars AJ; Bast EJ; de Gast GC; van de Winkel JG; de Lau WB
Ther Immunol; 1994 Oct; 1(5):279-87. PubMed ID: 7584502
[TBL] [Abstract][Full Text] [Related]
14. Enhanced antitumor effects of CD20 over CD19 monoclonal antibodies in a nude mouse xenograft model.
Hooijberg E; van den Berk PC; Sein JJ; Wijdenes J; Hart AA; de Boer RW; Melief CJ; Hekman A
Cancer Res; 1995 Feb; 55(4):840-6. PubMed ID: 7531616
[TBL] [Abstract][Full Text] [Related]
15. Degradation of radioiodinated B cell monoclonal antibodies: inhibition via a FCgamma-receptor-II-mediated mechanism and by drugs.
Vervoordeldonk SF; Balkenende AY; van den Berg H; von dem Borne AE; van der Schoot CE; Van Leeuwen EF; Slaper-Cortenbach IC
Cancer Immunol Immunother; 1996 Jan; 42(1):24-30. PubMed ID: 8625363
[TBL] [Abstract][Full Text] [Related]
16. Endocytosis and degradation of monoclonal antibodies targeting human B-cell malignancies.
Press OW; Farr AG; Borroz KI; Anderson SK; Martin PJ
Cancer Res; 1989 Sep; 49(17):4906-12. PubMed ID: 2667754
[TBL] [Abstract][Full Text] [Related]
17. Activation of B lymphocytes: integrating signals from CD19, CD22 and Fc gamma RIIb1.
Doody GM; Dempsey PW; Fearon DT
Curr Opin Immunol; 1996 Jun; 8(3):378-82. PubMed ID: 8793993
[TBL] [Abstract][Full Text] [Related]
18. Radioimmunotherapy in the pi-BCL1 B cell lymphoma model: efficacy depends on more than targeted irradiation alone.
Illidge T; Honeychurch J; Vandersteen A; Cragg M
Cancer Biother Radiopharm; 2000 Dec; 15(6):581-91. PubMed ID: 11190490
[TBL] [Abstract][Full Text] [Related]
19. Detailed studies on expression and function of CD19 surface determinant by using B43 monoclonal antibody and the clinical potential of anti-CD19 immunotoxins.
Uckun FM; Jaszcz W; Ambrus JL; Fauci AS; Gajl-Peczalska K; Song CW; Wick MR; Myers DE; Waddick K; Ledbetter JA
Blood; 1988 Jan; 71(1):13-29. PubMed ID: 3257143
[TBL] [Abstract][Full Text] [Related]
20. Inhibition, by vinca alkaloids and colchicine, of antigenic modulation induced by anti-CD19 monoclonal antibodies.
de Rie MA; Zeijlemaker WP; von dem Borne AE
Leuk Res; 1988; 12(2):135-41. PubMed ID: 3282129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
